In the TRAMP (transgenic adenocarcinoma of the mouse prostate) model of prostate cancer, MVA-TWIST/TRICOM treatment significantly increased overall survival in TRAMP transgenic (TRAMP-Tg) mice. Here, TWIST1 is linked to prostate carcinoma.